Mitsubishi UFJ Trust & Banking’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
RCMNY
CP
Mitsubishi UFJ Trust & Banking's ADMA Position: Q2 2026 in Review
Mitsubishi UFJ Trust & Banking opened a new position in ADMA Biologics (ADMA) in Q2 2026: 13,610 shares worth $114K. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: Mitsubishi UFJ Trust & Banking previously reported a position in ADMA as recently as Q4 2025.
Mitsubishi UFJ Trust & Banking first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $353K in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- Mitsubishi UFJ Trust & Banking held 13,610 shares of ADMA Biologics worth $114K as of Q2 2026.
- ADMA Biologics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
- ADMA Biologics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1481 holding.
- Mitsubishi UFJ Trust & Banking first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
- Mitsubishi UFJ Trust & Banking's ADMA Biologics position peaked at $353K in Q4 2025.
- 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.